FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.

Altre lingue Fujian Cosunter Pharmaceutical Co., Ltd.

Azioni

300436

CNE100001YZ0

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
16,88 ^CNY	-1,34%		+7,86%	-34,14%

19/04	Fujian Cosunter Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
2023	Fujian Cosunter Pharmaceutical Co., Ltd. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Jiangsu Zhongxing Pharm Co., Ltd. cancelled the transaction announced on July 5, 2021	29/12
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Fujian Cosunter Pharmaceutical Co., Ltd.(XSEC:300436) added to S&P Global BMI Index	18/09/23
Fujian Cosunter Pharmaceutical Co., Ltd. agreed to acquire remaining 5.8333% stake in Jiangsu Zhongxing Pharm Co., Ltd. from Zhang Zhijun for CNY 10.6 million.	12/09/23
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Cosunter Pharma Signs 14 Million Yuan Equipment Purchase Deal	27/06/23
Fujian Cosunter Pharma's Unit Completes Clinical Trials on COVID-19 Drug	21/06/23
Fujian Cosunter Pharma Gets Nod to Market Men's Drug	19/06/23
Fujian Cosunter Pharma Completes Enrollment for COVID-19 Drug; Shares Drop 3%	05/05/23
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20/04/23
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23
Fujian Cosunter Pharma Unit Gets Drug Production License from Provincial Regulator	15/03/23
Chinese Shares End Mixed; Cosunter Pharma Rallies 11% as COVID-19 Drug Seen More Effective Versus Pfizer's	10/01/23
Fujian Cosunter Pharma Says COVID-19 Drug More Effective Than Pfizer’s Paxlovid; Shares Rally 14%	10/01/23
Fujian Cosunter Pharma Selling 948 Million Yuan Shares to Fund New Drug Research Platform	09/01/23
Fujian Cosunter Pharmaceutical Co., Ltd. announced that it expects to receive CNY 948 million in funding	05/01/23
Fujian Cosunter Pharma Enrolls First Patient for Anti-COVID Drug Trial	22/12/22
Fujian Cosunter’s Trial of Anti-COVID Tablets Shows Drug’s Safety; Shares Up 4%	12/12/22
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Fujian Cosunter Pharmaceutical Co., Ltd.

Azioni

300436

CNE100001YZ0

Altre lingue

Filtri